37 related articles for article (PubMed ID: 1437957)
1. Simvastatin. A reappraisal of its cost effectiveness in dyslipidaemia and coronary heart disease.
Goa KL; Barradell LB; McTavish D
Pharmacoeconomics; 1997 Jan; 11(1):89-110. PubMed ID: 10172918
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of simvastatin (MK-733).
Stalenhoef AF; Mol MJ; Stuyt PM
Am J Med; 1989 Oct; 87(4A):39S-43S. PubMed ID: 2679083
[TBL] [Abstract][Full Text] [Related]
3. Benefits and risks assessment of simvastatin in familial hypercholesterolaemia.
Alonso R; Mata N; Mata P
Expert Opin Drug Saf; 2005 Mar; 4(2):171-81. PubMed ID: 15794711
[TBL] [Abstract][Full Text] [Related]
4. One year experience in the treatment of familial hypercholesterolaemia with simvastatin.
Quiney J; Watts GF; Kerr-Muir M; Slavin B; Lewis B
Postgrad Med J; 1992 Jul; 68(801):575-80. PubMed ID: 1437957
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.
Leclercq V; Harvengt C
Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications.
Watts GF; Cummings MH; Umpleby M; Quiney JR; Naoumova R; Thompson GR; Sönksen PH
Eur J Clin Invest; 1995 Aug; 25(8):559-67. PubMed ID: 7589011
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.
Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D
Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604
[TBL] [Abstract][Full Text] [Related]
8. Treatment of primary hypercholesterolaemia. Short-term efficacy and safety of increasing doses of simvastatin and pravastatin: a double-blind comparative study.
Stalenhoef AF; Lansberg PJ; Kroon AA; Kortmann B; De Haan AF; Stuyt PM; Kastelein JJ
J Intern Med; 1993 Jul; 234(1):77-82. PubMed ID: 8326293
[TBL] [Abstract][Full Text] [Related]
9. Effect of simvastatin on high density lipoprotein subfractions and apolipoproteins in type IIa hypercholesterolemia.
Crook D; Bruce R; Worthington M; Mulcahy D; Patterson D; Wynn V
Cardiovasc Drugs Ther; 1992 Dec; 6(6):633-9. PubMed ID: 1292582
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous side effects from use of triparanol (MER-29): preliminary data on ichthyosis and loss of hair.
ACHOR WP; WINKELMANN RK; PERRY HO
Proc Staff Meet Mayo Clin; 1961 Apr; 36():217-28. PubMed ID: 13681223
[No Abstract] [Full Text] [Related]
11. Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4124-8. PubMed ID: 6575399
[TBL] [Abstract][Full Text] [Related]
12. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia.
Stone NJ; Levy RI; Fredrickson DS; Verter J
Circulation; 1974 Mar; 49(3):476-88. PubMed ID: 4813182
[No Abstract] [Full Text] [Related]
13. Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis.
Ginsberg HN; Le NA; Short MP; Ramakrishnan R; Desnick RJ
J Clin Invest; 1987 Dec; 80(6):1692-7. PubMed ID: 3680522
[TBL] [Abstract][Full Text] [Related]
14. Effects of simvastatin on plasma lipid, lipoprotein and apolipoprotein concentrations in hypercholesterolaemia.
Mölgaard J; von Schenck H; Olsson AG
Eur Heart J; 1988 May; 9(5):541-51. PubMed ID: 3402470
[TBL] [Abstract][Full Text] [Related]
15. Immunoturbidimetric assays for serum apolipoproteins A1 and B using Cobas Bio centrifugal analyser.
Mount JN; Kearney EM; Rosseneu M; Slavin BM
J Clin Pathol; 1988 Apr; 41(4):471-4. PubMed ID: 3366936
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
